[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334837-105":59,"doc-detail-334837-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nanoparticle-mediated-synergistic-chemoimmunotherapy-for-cancer-treatment","Nanoparticle-Mediated Synergistic - Chemoimmunotherapy for Cancer Treatment","","Cancer treatment still lacks consistently effective strategies, especially when immunotherapy is used alone despite its strong potential across multiple cancer types. Chemoimmunotherapy offers a promising route, and understanding how chemotherapy and immunotherapy participate and synergize is central to improving outcomes. Nanoparticle-based drug delivery systems can co-target immune and cancer cells, enhance accumulation at tumor sites, and reduce systemic toxicity. This review summarizes key immunotherapies, chemotherapy-driven immunogenic mechanisms, and NDDS-mediated synergistic delivery approaches.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nanoparticle-mediated-synergistic-chemoimmunotherapy-for-cancer-treatment/334837/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nanoparticle-mediated-synergistic-chemoimmunotherapy-for-cancer-treatment/334837.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is chemoimmunotherapy considered important for cancer treatment?","Question",{"text":112,"@type":113},"Immunotherapy alone often has limited efficacy across cancer types. Chemoimmunotherapy combines chemotherapy with immune activation potential, aiming to improve treatment effectiveness and enable synergistic anti-tumor responses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How can nanoparticle-based drug delivery systems support chemoimmunotherapy?",{"text":117,"@type":113},"Nanoparticle-based delivery systems can simultaneously target immune cells and cancer cells, promote drug accumulation at relevant sites, and reduce drug toxicity by improving delivery and distribution.",{"name":119,"@type":110,"acceptedAnswer":120},"What immunotherapies and chemotherapy-driven mechanisms are discussed in the review?",{"text":121,"@type":113},"The review introduces immune checkpoint blocking, adoptive cell transfer, cancer vaccines, oncolytic virus therapy, and cytokine therapy. It also describes how chemotherapy can induce immunogenic cell death, enhance killer-cell infiltration, reduce immunosuppressive cells, and inhibit immune checkpoints, thereby strengthening synergy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334837,1792223728,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","International Journal of Nanomedicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article REVIEW  \nNanoparticle-Mediated Synergistic  \nChemoimmunotherapy for Cancer Treatment  \nXiaoxue Lang 1 , Xiangtao Wang 1 , Meihua Han 1 , Yifei Guo 1–4  \n1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China; 2Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China; 3Key Laboratory of New Drug Discovery Based on Classic Chinese Medicine Prescription, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 4Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, People’s Republic of China  \nCorrespondence: Yifei Guo, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing, 100193, People’s Republic of China, Tel +86 18810811910, Email [ffguo@163.com](ffguo@163.com)  \n\n| Abstract: Until now, there has been a lack of effective strategies for cancer treatment. Immunotherapy has high potential in treating several cancers but its efficacy is limited as a monotherapy. Chemoimmunotherapy (CIT) holds promise to be widely used in cancer treatment. Therefore, identifying their involvement and potential synergy in CIT approaches is decisive. Nano-based drug delivery systems (NDDSs) are ideal delivery systems because they can simultaneously target immune cells and cancer cells, promoting drug accumulation, and reducing the toxicity of the drug. In this review, we first introduce five current immunotherapies, including immune checkpoint blocking (ICB), adoptive cell transfer therapy (ACT), cancer vaccines, oncolytic virus therapy (OVT) and cytokine therapy. Subsequently, the immunomodulatory effects of chemotherapy by inducing immunogenic cell death (ICD), promoting tumor killer cell infiltration, down-regulating immunosuppressive cells, and inhibiting immune checkpoints have been described. Finally, the NDDSsmediated collaborative drug delivery systems have been introduced in detail, and the development of NDDSs-mediated CIT nanoparticles has been prospected.\u003Cbr>Keywords: chemoimmunotherapy, chemotherapy, immunotherapy, NDDSs |\n| --- |\n| Introduction\u003Cbr>Cancer is a global health problem, for example, in the United States alone, 2,001,140 new cancer cases and 611,720 cancer-related deaths are expected to occur in 2024.1 For decades, the most widely used traditional treatments used by cancer patients have been surgery, chemotherapy and radiotherapy. Surgery and radiotherapy are effective for local and non-metastatic cancers but struggle to work when the cancer has spread. Emerging therapies, including gene therapy and hormone therapy, are also attracting researchers’ attention. Gene therapy manipulates cells by introducing genetic material into cells that do not function properly. Gene therapy is still experimental and there is no guarantee it will have a positive effect on everyone. After the infusion, the body’s immune system may respond differently to the virus carrying the altered gene, with a low fault tolerance rate. Hormone therapies work by interfering with hormone signals, and they may attack different parts of the signaling pathway to slow the growth of cancer. Hormone therapy is usually combined with surgery/radiation/chemotherapy. In these cases, hormone therapy is considered an adjunct therapy. Chemotherapy is a way of selectively destroying tumor cells or at least limiting their proliferation using low molecular weight drugs.2 Cancer drugs can reach all organs of the body through the bloodstream, so chemotherapy is currently the preferred me","cbCaigi4grYNOwEu","https://ap.wps.com/l/cbCaigi4grYNOwEu","pdf",10765137,36,"English","# Abstract\n# Introduction\n## Cancer as a global health problem\n## Limitations of traditional therapies\n## Rationale for chemotherapy and its challenges\n## Immunotherapy and emerging combination approaches","[{\"question\":\"Why is chemoimmunotherapy considered important for cancer treatment?\",\"answer\":\"Immunotherapy alone often has limited efficacy across cancer types. Chemoimmunotherapy combines chemotherapy with immune activation potential, aiming to improve treatment effectiveness and enable synergistic anti-tumor responses.\"},{\"question\":\"How can nanoparticle-based drug delivery systems support chemoimmunotherapy?\",\"answer\":\"Nanoparticle-based delivery systems can simultaneously target immune cells and cancer cells, promote drug accumulation at relevant sites, and reduce drug toxicity by improving delivery and distribution.\"},{\"question\":\"What immunotherapies and chemotherapy-driven mechanisms are discussed in the review?\",\"answer\":\"The review introduces immune checkpoint blocking, adoptive cell transfer, cancer vaccines, oncolytic virus therapy, and cytokine therapy. It also describes how chemotherapy can induce immunogenic cell death, enhance killer-cell infiltration, reduce immunosuppressive cells, and inhibit immune checkpoints, thereby strengthening synergy.\"}]","Nanoparticle-Mediated Synergistic - Chemoimmunotherapy for Cancer Treatment | PDF",1790008504,91]